By partnering with Siemens Healthcare Diagnostics, you can experience the assurance of an integrated hemostasis solution that can help improve both clinical and operational performance throughout your entire laboratory. Our INNOVANCE® line will help you gain efficiencies, increase operational workflow and throughput, and better manage your resources.
INNOVANCE Heparin Assay
Our INNOVANCE Heparin Assay* quantitatively determines the activity of unfractionated (UF) and low-molecular-weight (LMW) heparin in citrated plasma. Liquid reagents and a single hybrid calibration curve for UF and LMW heparin help deliver precise results in fewer steps.
Our INNOVANCE D-Dimer assay helps labs exclude deep vein thrombosis (DVT) and pulmonary embolism (PE) in conjunction with a non-high clinical pretest probability (PTP) asssesment model.
Our INNOVANCE Antithrombin assay provides better sensitivity for antithrombin type II defects.
INNOVANCE PFA P2Y
Our INNOVANCE PFA P2Y cartridge* reliably detects the blockade of P2Y12 receptors, i.e. Plavix® (Clopidogrel).
Our INNOVANCE ETP assay* is a new, innovative measure of global coagulability developed for routine clinical use.
INNOVANCE Free PS Ag
INNOVANCE Free PS Ag assay* provides a quantitative determination of protein S in human plasma based on state-of-the-art technology. The assay provides easy, highly specific and stable protein S antigen testing.
INNOVANCE VWF Ac
INNOVANCE VWF Ac assay* provides reliable, precise and senitive VWF determination. The significantly improved sensitivity ensures a convenient and economical VWF determination to optimize the labs VWF testing capability.